Persistent URL of this record https://hdl.handle.net/1887/101814
In Collections
This item can be found in the following collections:
![LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL
- All authors
- Sieper, J.; Rudwaleit, M.; Heijde, D. van der; Maksymowych, W.; Dougados, M.; Mease, P.J.; Braun, J.; Deodhar, A.; Hoepken, B.; Nurminen, T.; Landewe, R.
- Date
- 2014-06-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 73
- Pages
- 719 - 720